v3.26.1
ORGANIZATION AND BASIS OF PRESENTATION (Tables)
6 Months Ended
Jun. 30, 2026
ORGANIZATION AND BASIS OF PRESENTATION  
Summary of principal subsidiaries

As of June 30, 2026, the Company’s principal subsidiaries were as follows:

Percentage of legal

Date of

Place of

ownership

Entity

  ​ ​ ​

incorporation

  ​ ​ ​

incorporation

  ​ ​ ​

by the Company

  ​ ​ ​

Principal activities

Adagene (Hong Kong) Limited

December 12, 2011

 

Hong Kong

 

100

%

Investment holding, and research and development of innovative medicines

Adagene Incorporated

September 20, 2017

 

The United States of America

 

100

%

Research and development of innovative medicines

Adagene (Suzhou) Limited

February 28, 2012

 

The People’s Republic of China (“PRC” or “China”)

 

100

%

Research and development of innovative medicines

Adagene Australia PTY Ltd.

May 30, 2018

Australia

100

%

Research and development of innovative medicines

Adagene PTE. Ltd.

March 27, 2020

Singapore

100

%

Research and development of innovative medicines

Adagene AG

August 31, 2020

 

Switzerland

 

100

%

Research and development of innovative medicines

Adagene Project C1 PTE. Ltd.

March 25, 2022

 

Singapore

 

100

%

Research and development of innovative medicines